23andMe Wants To Turn Your DNA Data Into Lucrative New Drugs

March 13, 2015 11:05 AM

4 0

23andMe's original business model may have been thwarted by the feds, but that isn't stopping the company from trying new ways to generate revenue. Its latest idea could be a lucrative one: invent new drugs.

23andMe is sitting on a mountain of genetic data culled from the more than 800,000 people who took its genetic tests before they were pulled from the market. The idea here is to mine that massive data set for as-yet-unseen insights, which could inform pharmaceutical research. The company intends to ...

Read more

To category page